Personnel

Cytori Therapeutics appoints cardiovascular clinical advisory board

Published in Heart Disease Weekly, May 2nd, 2006

Cytori Therapeutics, Inc. (CYTX) (XMPA) announced the appointment of an independent cardiovascular clinical advisory board comprised of internationally renowned experts in cardiology and cardiovascular imaging. This board will be instrumental in guiding the development of Cytori's adipose-derived stem cell-based therapies for cardiovascular disease.

"This board consists of preeminent experts in their respective fields who are recognized as pioneers in cardiovascular medicine and clinical research," said Alex M. Milstein, MD, vice president of clinical development for Cytori Therapeutics. "I am delighted that these distinguished clinicians and scientists have agreed to...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Heart Disease Weekly

Source: Heart Disease Weekly (2006-05-02)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry